Progyny, Inc. to Present at Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum

Rhea-AI Summary

Progyny, Inc. (Nasdaq: PGNY) to participate in fireside chat at Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum on November 16, 2023. CEO and CFO to discuss company's role in fertility and family building benefits solutions. Live audiocast and replay available on Progyny's website.

Positive

• Progyny's participation in the forum indicates its commitment to engaging with investors and stakeholders, potentially boosting investor confidence.
• The event provides an opportunity for the CEO and CFO to highlight Progyny's expertise in the fertility and family building benefits solutions sector, potentially attracting new investors and clients.

Negative

• None.

NEW YORK, Nov. 10, 2023 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions, today announced that Pete Anevski, Progyny’s Chief Executive Officer, and Mark Livingston, Chief Financial Officer, will participate in a fireside chat at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum on Thursday, November 16, 2023, at 10:30 A.M. Eastern Time.

A live audiocast and replay will be available from the Events and Presentations section of Progyny’s website at http://investors.progyny.com.

About Progyny

Progyny (Nasdaq: PGNY) is a leading fertility benefits management company. We are redefining fertility and family building benefits, proving that a comprehensive and inclusive solution can simultaneously benefit employers, patients, and physicians.

Our benefits solution empowers patients with education and guidance from a dedicated Patient Care Advocate (PCA), provides access to a premier network of fertility specialists using the latest science and technologies, reduces healthcare costs for the nation’s leading employers, and drives optimal clinical outcomes. We envision a world where anyone who wants to have a child can do so.

Headquartered in New York City, Progyny has been recognized for its leadership and growth by CNBC Disruptor 50, Modern Healthcare’s Best Places to Work in Healthcare, Financial Times, INC. 5000, and Crain’s Fast 50 for NYC. For more information, visit www.progyny.com.

For Further Information, Please Contact:

Investors:
James Hart
investors@progyny.com

Media:
Selena Yang
media@progyny.com

FAQ

What is Progyny, Inc. participating in on November 16, 2023?

Progyny, Inc. (Nasdaq: PGNY) is participating in a fireside chat at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum.

Where can the audiocast and replay of the event be accessed?

The live audiocast and replay will be available from the Events and Presentations section of Progyny’s website at http://investors.progyny.com.